Genomic Valley Biotech
GVBLBSE

Genomic Valley Biotech

₹26.540.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
26.54
Today’s high
26.54
52 week low
20.10
52 week high
54.27
Open price
26.54
Previous close
26.54
Live volume
50
Lower circuit
25.22
Upper circuit
27.86

Fundamentals

Market Cap
₹8.11Cr
ROE
0.77%
P/E Ratio(TTM)
265.40
EPS(TTM)
0.10
P/B Ratio
2.07
Dividend Yield
0.00%
Industry P/E
59.58
Book Value
12.85
Debt to Equity
0.00
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹0.04
-20.00%
Profit (Cr)
-₹0.01
-200.00%
-2-1012
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-85%
3Y CAGR+76%
Profit growthValue
1Y (TTM)+700%
3Y CAGR+242%

About

Genomic Valley Biotech Ltd. is at the forefront of revolutionizing healthcare by integrating advanced technologies like Next-Generation Sequencing (NGS) into biotechnology and health solutions. The company envisions a future where cutting-edge technology and human expertise combine to transform molecular diagnostics, improving patient outcomes and advancing global healthcare. Its mission involves using Artificial Intelligence to simplify tasks for healthcare professionals, making diagnostics more accurate, personalizing treatments, and increasing overall healthcare efficiency. The company provides precise and rapid molecular diagnostic services using NGS and AI, which enables early detection and personalized treatment plans for oncology patients. It also offers comprehensive Research Process Outsourcing (RPO) to global researchers, utilizing a dedicated team and software tools to ensure refined data analysis and optimal solutions. Inspired by a national vision, the company aims to establish a 'Silicon Valley of genomics' in India, becoming a global hub for genomic research and diagnostics.;
CEO/MD
Mr. Yogesh Agrawal
Founded in
1994
BSE symbol
539206

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Retail And Others
53.94%
Promoters
46.06%
2026
29
May
Quarterly & Annual Result
Release date
15
Jan
Quarterly Result
Release date
2025
15
Oct
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks